Abstract
Transition metal complexes capable of near-infrared light triggered-cytotoxicity are actively being developed as potential photosensitizers (PS) for photodynamic therapy (PDT) of cancers. In the present work, the structures and photophysical properties of complexes Pt(NˆCˆN)Cl and Pd(NˆCˆN)Cl (NˆCˆN = 2,6-dipyrido-4-methyl-benzenechloride) are investigated with a theoretical approach. The features of low-lying singlet and triplet excited states are discussed in detail. Their potential therapeutic use as two-photon PS in PDT is proposed on the basis of their strong absorbance in near-infrared region (NIR), vertical triplet energies resulting higher than 0.98 eV, and the spin-orbit matrix elements lager than 0.24 cm−1. Moreover, an evaluation of triplet excited states lifetime is presented. The longer lifetime of the triplet excited states would lead to higher 1O2 yields for Pd(NˆCˆN)Cl compared to Pt(NˆCˆN)Cl. It is expected that the low-cost Pd(NˆCˆN)Cl will replace the reported Pt(NˆCˆN)Cl as a promising two-photon PS for improving clinical PDT efficacy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
